PLASMACYTOMA

Clinical trials for PLASMACYTOMA explained in plain language.

Never miss a new study

Get alerted when new PLASMACYTOMA trials appear

Sign up with your email to follow new studies for PLASMACYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Terminated 1

New CAR-T combo targets tough myeloma early

Disease control Recruiting now

This early-phase trial tests a combination CAR-T cell therapy that targets two cancer markers (BCMA and GPRC5D) in people with high-risk multiple myeloma or plasmacytoma. The goal is to see if this treatment is safe and can control the disease as a first-line therapy. About 20 pa…

Matched conditions: PLASMACYTOMA

Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control

Last updated May 11, 2026 20:40 UTC

PLASMACYTOMA

Get alerted when new PLASMACYTOMA trials appear

New CAR-T combo targets tough myeloma early